Stay updated on Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial
Sign up to get notified when there's something new on the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page.

Latest updates to the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2 on the page.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page now shows Revision: v3.4.1 replacing the previous Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedGlossary visibility was added; QC-related metadata now shows 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', and 'No FEAR Act Data' was added. The previously displayed items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no observable changes to the study page content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check69 days agoChange DetectedA Locations section was updated to include new study sites across multiple countries and regions (US states and international locations), and some existing location entries were removed.SummaryDifference1%

- Check91 days agoChange DetectedAdded a notice that publications are automatically filled from PubMed and may not be about the study. Updated the revision tag to v3.3.2, replacing the previous v3.2.0 text.SummaryDifference0.1%

Stay in the know with updates to Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page.